Occudo Quantitative Strategies’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-6,433
Closed -$286K – 844
2024
Q4
$286K Buy
+6,433
New +$289K 0.05% 463
2024
Q2
– Sell
-16,903
Closed -$494K – 928
2024
Q1
$494K Buy
16,903
+10,895
+181% +$330K 0.09% 308
2023
Q4
$226K Sell
6,008
-2,842
-32% -$105K 0.03% 622
2023
Q3
$399K Buy
+8,850
New +$536K 0.05% 568
2023
Q2
– Sell
-3,454
Closed -$203K – 1205
2023
Q1
$203K Sell
3,454
-20,374
-86% -$1.12M 0.02% 751
2022
Q4
$1.2M Sell
23,828
-5,506
-19% -$331K 0.14% 233
2022
Q3
$2.55M Buy
29,334
+25,783
+726% +$2.71M 0.2% 139
2022
Q2
$404K Buy
+3,551
New +$408K 0.03% 700

Other funds holding OMCL

Occudo Quantitative Strategies's OMCL Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Omnicell (OMCL) in Q1 2025, closing a stake of 6,433 shares — an estimated $286K sold.

Occudo Quantitative Strategies first reported a position in OMCL in Q2 2022 and held it in 8 quarters. The position peaked at $2.55M in Q3 2022. 274 funds tracked by Wall St. Rank hold OMCL as of Q1 2025.

  • Occudo Quantitative Strategies reported no remaining Omnicell position as of Q1 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,433 Omnicell shares in Q1 2025, an estimated $286K.
  • Occudo Quantitative Strategies first reported a position in Omnicell in Q2 2022 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Omnicell position peaked at $2.55M in Q3 2022.
  • 274 funds tracked by Wall St. Rank held Omnicell as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.